These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28932684)

  • 1. Value of combining dynamic contrast enhanced ultrasound and optoacoustic tomography for hypoxia imaging.
    Shah A; Bush N; Box G; Eccles S; Bamber J
    Photoacoustics; 2017 Dec; 8():15-27. PubMed ID: 28932684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-Enhanced and Dynamic Contrast-Enhanced Optoacoustic Tomography Provide Surrogate Biomarkers of Tumor Vascular Function, Hypoxia, and Necrosis.
    Tomaszewski MR; Gehrung M; Joseph J; Quiros-Gonzalez I; Disselhorst JA; Bohndiek SE
    Cancer Res; 2018 Oct; 78(20):5980-5991. PubMed ID: 30115696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multispectral optoacoustic tomography of the human breast: characterisation of healthy tissue and malignant lesions using a hybrid ultrasound-optoacoustic approach.
    Becker A; Masthoff M; Claussen J; Ford SJ; Roll W; Burg M; Barth PJ; Heindel W; Schäfers M; Eisenblätter M; Wildgruber M
    Eur Radiol; 2018 Feb; 28(2):602-609. PubMed ID: 28786007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A light-fluence-independent method for the quantitative analysis of dynamic contrast-enhanced multispectral optoacoustic tomography (DCE MSOT).
    Hupple CW; Morscher S; Burton NC; Pagel MD; McNally LR; Cárdenas-Rodríguez J
    Photoacoustics; 2018 Jun; 10():54-64. PubMed ID: 29988890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of optoacoustic breast imaging and future trends in clinical application: is it ready for prime time?
    Ozcan BB; Wanniarachchi H; Mason RP; Dogan BE
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38308678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
    Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
    PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography.
    Noltes ME; Bader M; Metman MJH; Vonk J; Steinkamp PJ; Kukačka J; Westerlaan HE; Dierckx RAJO; van Hemel BM; Brouwers AH; van Dam GM; Jüstel D; Ntziachristos V; Kruijff S
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2736-2750. PubMed ID: 37039901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
    Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motion Rejection and Spectral Unmixing for Accurate Estimation of In Vivo Oxygen Saturation Using Multispectral Optoacoustic Tomography.
    Sarkar M; Perez-Liva M; Renault G; Tavitian B; Gateau J
    IEEE Trans Ultrason Ferroelectr Freq Control; 2023 Dec; 70(12):1671-1681. PubMed ID: 37603493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging.
    Lin X; Yang C; Lv Y; Zhang B; Kan J; Li H; Tao J; Yang C; Li X; Liu Y
    J Biophotonics; 2024 Apr; 17(4):e202300457. PubMed ID: 38221652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of conventional ultrasound, contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging in assessing the size of breast cancer.
    Shi XQ; Dong Y; Tan X; Yang P; Wang C; Feng W; Lin Y; Qian L
    Clin Hemorheol Microcirc; 2022; 82(2):157-168. PubMed ID: 35723092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic 2-deoxy-D-glucose-enhanced multispectral optoacoustic tomography for assessing metabolism and vascular hemodynamics of breast cancer.
    Han Z; MacCuaig WM; Gurcan MN; Claros-Sorto J; Garwe T; Henson C; Holter-Chakrabarty J; Hannafon B; Chandra V; Wellberg E; McNally LR
    Photoacoustics; 2023 Aug; 32():100531. PubMed ID: 37485041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT.
    Huang W; Wang K; An Y; Meng H; Gao Y; Xiong Z; Yan H; Wang Q; Cai X; Yang X; Zhang B; Chen Q; Yang X; Tian J; Zhang S
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1027-1038. PubMed ID: 31705175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
    Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
    Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image processing improvements afford second-generation handheld optoacoustic imaging of breast cancer patients.
    Kukačka J; Metz S; Dehner C; Muckenhuber A; Paul-Yuan K; Karlas A; Fallenberg EM; Rummeny E; Jüstel D; Ntziachristos V
    Photoacoustics; 2022 Jun; 26():100343. PubMed ID: 35308306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-Mode Volumetric Optoacoustic and Contrast Enhanced Ultrasound Imaging With Spherical Matrix Arrays.
    Robin J; Ozbek A; Reiss M; Dean-Ben XL; Razansky D
    IEEE Trans Med Imaging; 2022 Apr; 41(4):846-856. PubMed ID: 34735340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic Perfusion Analysis of Quadriceps, Patellar, and Achilles Tendon Regeneration With Dynamic Contrast-Enhanced Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Preliminary Results.
    Fischer C; Miska M; Jung A; Weber MA; Saure D; Schmidmaier G; Weimer A; Moghaddam A; Doll J
    J Ultrasound Med; 2021 Mar; 40(3):491-501. PubMed ID: 32785982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imaging.
    Lin S; Shah A; Hernández-Gil J; Stanziola A; Harriss BI; Matsunaga TO; Long N; Bamber J; Tang MX
    Photoacoustics; 2017 Jun; 6():26-36. PubMed ID: 28507898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying dynamic contrast enhanced MSOT imaging to intratumoral pharmacokinetic modeling.
    Xiao TG; Weis JA; Gayzik FS; Thomas A; Chiba A; Gurcan MN; Topaloglu U; Samykutty A; McNally LR
    Photoacoustics; 2018 Sep; 11():28-35. PubMed ID: 30105204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Modality Surface-Enhanced Resonance Raman Scattering and Multispectral Optoacoustic Tomography Nanoparticle Approach for Brain Tumor Delineation.
    Neuschmelting V; Harmsen S; Beziere N; Lockau H; Hsu HT; Huang R; Razansky D; Ntziachristos V; Kircher MF
    Small; 2018 Jun; 14(23):e1800740. PubMed ID: 29726109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.